BSEMacfos LtdMediumNeutral
Announced Sat, 2 May · 16:16 IST

Pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Please find enclosed herewith the transcript of the Earnings Conference ....

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.0%1-day move
₹1000.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-9.0-1.0-6.8-7.0-3.1+8.4+13.1+27.8+15.5
Up moveDown movePending
AI summary

Macfos Ltd reported FY 2025-26 revenue of INR312 crores with EBITDA of INR39 crores and PAT of INR25.65 crores. Excluding one-time bulk sales of INR71 crores from prior year H1, this represents strong 67% YoY revenue growth, 103% EBITDA growth, and 105% PAT growth. The company operates two segments: Robu 1.0 (electronics distribution) as the core business backbone, and Robu 2.0 (proprietary products including drones under SmartElex brand). Management highlighted that own-brand products command approximately 10% higher gross margins than regular distribution products. Average order value has increased from sub-INR5000 to INR6500-7000 due to market maturation and portfolio expansion. The company is seeing traction from B2B and B2G customers including government/defense engagements for drones, though management clarified this is currently low-value and low-volume. The company clarified data discrepancies in earlier presentations and emphasized inventory management as a key strength.

Likely market impact

Strong execution with healthy margin expansion. The shift toward proprietary products (ROBU 2.0) with 10% margin premium provides a natural hedge against distribution margin pressure as the business scales. Defense sector engagement is early-stage and should be watched for material revenue contribution over the next 1-2 years.